{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:27:30Z","timestamp":1648513650068},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12328-020-01124-5","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T07:03:42Z","timestamp":1588143822000},"page":"847-854","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A case of complete remission of advanced hepatocellular carcinoma with type III portal vein tumor thrombosis treated using transarterial chemoembolization with microspheres and radiation therapy"],"prefix":"10.1007","volume":"13","author":[{"given":"Daizo","family":"Fukushima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohichi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Horikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Shiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Koyanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,29]]},"reference":[{"key":"1124_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/hep.510290145","volume":"29","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Bustamante J, Castells A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29:62\u20137.","journal-title":"Hepatology"},{"key":"1124_CR2","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer","year":"2012","unstructured":"European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. J Hepatol. 2012;56:908\u201343.","journal-title":"J Hepatol"},{"key":"1124_CR3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S1479-666X(05)80043-5","volume":"3","author":"EC Lai","year":"2005","unstructured":"Lai EC, Lau WY. The continuing challenge of hepatic cancer in Asia. Surgeon. 2005;3:210\u20135.","journal-title":"Surgeon."},{"key":"1124_CR4","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/00000658-200204000-00004","volume":"235","author":"RT Poon","year":"2002","unstructured":"Poon RT, Fan ST, Tsang FH, et al. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon\u2019s perspective. Ann Surg. 2002;235:466\u201386.","journal-title":"Ann Surg"},{"key":"1124_CR5","doi-asserted-by":"publisher","first-page":"7561","DOI":"10.3748\/wjg.v12.i47.7561","volume":"12","author":"M Minagawa","year":"2006","unstructured":"Minagawa M, Makuuchi M. Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol. 2006;12:7561\u20137.","journal-title":"World J Gastroenterol"},{"key":"1124_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00534-010-0314-0","volume":"18","author":"J Shi","year":"2011","unstructured":"Shi J, Lai EC, Li N, et al. A new classification for hepatocellular carcinoma with portal vein tumor thrombus. J Hepatobil Pancreat Sci. 2011;18:74\u201380.","journal-title":"J Hepatobil Pancreat Sci."},{"key":"1124_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jhep.2012.06.014","volume":"57","author":"J Bruix","year":"2012","unstructured":"Bruix J, Raoul JL, Sherman M, et al. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial. J Hepatol. 2012;57:821\u20139.","journal-title":"J Hepatol"},{"key":"1124_CR8","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/jcp.27324","volume":"234","author":"JC Wang","year":"2019","unstructured":"Wang JC, Xia AL, Xu Y, et al. Comprehensive treatments for hepatocellular carcinoma with portal vein tumor thrombosis. J Cell Physiol. 2019;234:1062\u201370.","journal-title":"J Cell Physiol"},{"key":"1124_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003015","author":"K Wang","year":"2016","unstructured":"Wang K, Guo WX, Chen MS, et al. Multimodality treatment for hepatocellular carcinoma with portal vein tumor thrombus: a large-scale, multicenter, propensity mathching score analysis. Medicine (Baltimore). 2016. https:\/\/doi.org\/10.1097\/MD.0000000000003015.","journal-title":"Medicine (Baltimore)."},{"key":"1124_CR10","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1007\/s12032-011-0145-0","volume":"29","author":"ZJ Niu","year":"2012","unstructured":"Niu ZJ, Ma YL, Kang P, et al. Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification. Med Oncol. 2012;29:2992\u20137.","journal-title":"Med Oncol"},{"key":"1124_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5009\/gnl.2012.6.2.139","volume":"6","author":"IJ Lee","year":"2012","unstructured":"Lee IJ, Seong J. The optimal selection of radiotherapy treatment for hepatocellular carcinoma. Gut Liver. 2012;6:139\u201348.","journal-title":"Gut Liver."},{"key":"1124_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/liv.13191","volume":"37","author":"JH Im","year":"2017","unstructured":"Im JH, Yoon SM, Park HC, et al. Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area. Liver Int. 2017;37:90\u2013100.","journal-title":"Liver Int."},{"key":"1124_CR13","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3748\/wjg.v10.i6.825","volume":"10","author":"MS Huang","year":"2004","unstructured":"Huang MS, Lin Q, Jiang ZB, et al. Comparison of long-term effects between intra-arterially delivered ethanol and Gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma. World J Gastroenterol. 2004;10:825\u20139.","journal-title":"World J Gastroenterol"},{"key":"1124_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.radcr.2016.11.006","volume":"12","author":"Y Imai","year":"2016","unstructured":"Imai Y, Hirooka M, Koizumi Y, et al. Histological assessment of the efficacy of drug-eluting beads in portal tumor thrombosis of hepatocellular carcinoma. Radiol Case Rep. 2016;12:179\u201384.","journal-title":"Radiol Case Rep."},{"key":"1124_CR15","doi-asserted-by":"publisher","first-page":"808","DOI":"10.4254\/wjh.v9.i18.808","volume":"28","author":"JE Song","year":"2017","unstructured":"Song JE, Kim DY. Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma. World J Hepatol. 2017;28:808\u201314.","journal-title":"World J Hepatol."},{"key":"1124_CR16","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2147\/CMAR.S193948","volume":"11","author":"YD Xiao","year":"2019","unstructured":"Xiao YD, Ma C, Zhang ZS, et al. Safety and efficacy assessment of transarterial chemoembolization using drug-eluting beads in patients with hepatocellular carcinoma and arterioportal shunt: a single-center experience. Cancer Manag Res. 2019;11:1551\u20137.","journal-title":"Cancer Manag Res."}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-020-01124-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-020-01124-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-020-01124-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:33:17Z","timestamp":1619656397000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-020-01124-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,29]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1124"],"URL":"https:\/\/doi.org\/10.1007\/s12328-020-01124-5","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,29]]},"assertion":[{"value":"3 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Daizo Fukushima,Shigeki Imai, Noriyuki Nishino, Kohichi Hamada, Yasunori Horikawa, Yoshiki Shiwa, Shinya Nishida, Ryota Koyanagi, Hitoshi Wada, Hideo Sakuma declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights"}},{"value":"Informed consent was obtained from all patients for being included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}